Inactive Instrument

Ibere Pharmaceuticals

IBER

KYG468431013

Ibere Pharmaceuticals Reports Earnings Results for the Second Quarter Ended June 30, 2021

August 17, 2021 at 02:54 am IST

Ibere Pharmaceuticals announced earnings results for the second quarter ended June 30, 2021. For the second quarter, the company announced operating loss was USD 233,757. Net loss was USD 112,267. For the half year, operating loss was USD 328,235. Net loss was USD 517,965.

Latest news about Ibere Pharmaceuticals

Ibere Pharmaceuticals Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	15/22/15	CI
Ibere Pharmaceuticals Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022	13/22/13	CI
Ibere Pharmaceuticals Reports Earnings Results for the First Quarter Ended March 31, 2022	16/22/16	CI
Ibere Pharmaceuticals Reports Earnings Results for the Full Year Ended December 31, 2021	01/22/01	CI
Ibere Pharmaceuticals Auditor Raises 'Going Concern' Doubt	31/22/31	CI
Ibere Pharmaceuticals Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2021	13/21/13	CI
Certain Class B Ordinary Shares of Ibere Pharmaceuticals are subject to a Lock-Up Agreement Ending on 24-AUG-2021.	24/21/24	CI
Ibere Pharmaceuticals Reports Earnings Results for the Second Quarter Ended June 30, 2021	17/21/17	CI
Ibere Pharmaceuticals announced that it has received $4.835 million in funding	02/21/02	CI
Ibere Pharmaceuticals has completed an IPO in the amount of $120 million.	26/21/26	CI
Ibere Pharmaceuticals announced that it expects to receive $4.835 million in funding	25/21/25	CI
Ibere Pharmaceuticals has filed an IPO in the amount of $100 million.	08/21/08	CI

Chart Ibere Pharmaceuticals

Duration

Period

More charts

Company Profile

Ibere Pharmaceuticals is a blank check company. The Company is created for the purpose is to effect a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses. The Company focuses on healthcare sector. The Company has no operations and has not generated revenues.

Sector

Investment Holding Companies

More about the company

Sector Shell Companies

	1st Jan change	Capi.
TRUMP MEDIA & TECHNOLOGY GROUP CORP.	+166.80%	6.38B
SCREAMING EAGLE ACQUISITION CORP.	+1.65%	1.01B
CHURCHILL CAPITAL CORP VII	+2.05%	981M
APPLE ISPORTS GROUP, INC.	+41.91%	872M
PERELLA WEINBERG PARTNERS	+24.28%	812M
ARES ACQUISITION CORPORATION II	+1.72%	664M
E7 GROUP	+1.80%	617M
DA ZHONG TRADING GROUP HOLDING COMPANY	-.--%	600M
ALTC ACQUISITION CORP.	+36.55%	622M

Shell Companies